期刊文献+

我国医药制造上市公司专利水平与公司业绩协整分析 被引量:3

The Cointegration Analysis on Patents and Enterprises' Performance in Listed Pharmaceutical Sector
下载PDF
导出
摘要 运用计量经济学协整分析和Granger因果关系分析相关理论,对我国医药制造行业上市公司发明、实用新型和外观设计专利授权量与公司业绩之间的相互关系进行了实证分析。证明了企业的发明、实用新型和外观设计专利与企业业绩之间存在着长期稳定的动态均衡关系,并且发明、实用新型专利与企业业绩之间存在显著的因果关系,外观设计专利与企业业绩之间存在互为因果的关系,目前我国医药制造行业中外观设计专利对于公司业绩水平的贡献程度最大。 This paper empirically analyzes the relationship between invention patents, utility model patents, design patents and enterprises' financial performance, with the help of econometric theories related to cointegration and Granger causality analysis. The results show that there are long- term equilibriums between invention patents, utility model patents, design patents and enterprises' prime operating revenues. Besides, invention patents and utility model patents are the Granger cause of enterprises' prime operating revenues, while, between design patents and enterprises' prime operating revenues,there are Granger causes with each other. What is more, it is the design patent that is making the maximum contribution to the enterprises' prime operating revenues.
作者 唐恒 金志成
出处 《科技管理研究》 CSSCI 北大核心 2012年第8期180-183,188,共5页 Science and Technology Management Research
关键词 医药制造 专利 公司业绩 协整分析 pharmaceutical manufacturing patent enterprises' financial performance cointegration analysis
  • 相关文献

参考文献13

二级参考文献87

共引文献238

同被引文献28

  • 1索玮岚,高军,陈锐.科研机构科技资源使用效益评估研究——基于时滞效应和关联效应视角[J].科学学研究,2015,33(2):234-241. 被引量:17
  • 2BAGLIERI D, CESARONI F. Capturing the real value of patent a- nalysis for R&D strategies [ J ]. Technology Analysis & Strategic Management, 2013, 25 (8): 971-986.
  • 3REITZIG M. Strategic management of intellectual property [ J]. M1T Sloan Management Review, 2004, 45 (3) : 35 - 40.
  • 4ANANDARAJAN A, CHIN C - L, CHI H - Y. The effect of innova- tive activity on firm performance: the experience ofTaiwan [J]. Ad- vances in Accounting, 2007, 23 ( 1 ) : 1 - 30.
  • 5CHEN Y - S, CHANG K - C. The nonlinear nature of the relation- ships between the patent traits and corporate performance [ J ].Seien- tometries, 2010, 82 (1): 201-210.
  • 6ERNST H. Patent applications and subsequent changes of perform- ance : evidence from time - series cross - section analyses on the firm level [J]. Research Policy, 2001, 30 (1) : 143 - 157.
  • 7CHANG K - C, CHEN D - Z, HUANG M - H. The relationships between the patent performance and corporation performance [ J ]. Journal oflnformetrics, 2012, 6 (1): 131-139.
  • 8CHEN Y - S, CHANG K - C. The relationship between a firm pa- tent quality and its market value : the case of US pharmaceutical in- dustry [J]. Technological Forecasting and Social Change, 2010, 77 (1): 20-33.
  • 9YU - SHAN C, KE - CHIUN C. Exploring the nonlinear effects of patent citations, patent share and relative patent position on market value in the US pharmaceutical industry [ J ]. Technology Analysis & Strategic Management, 2010, 22 (2) : 153 - 169.
  • 10ARTZ K W, NORMAN P M, HATFIELD D E. A longitudinal study of the impact of R&D, patents, and product innovation on firm performance [ J ]. Journal of Product Innovation Management, 2010, 27 (5): 725-740.

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部